Endoglin (ENG)

The protein contains 658 amino acids for an estimated molecular weight of 70578 Da.

 

Vascular endothelium glycoprotein that plays an important role in the regulation of angiogenesis (PubMed:21737454, PubMed:23300529). Required for normal structure and integrity of adult vasculature (PubMed:7894484). Regulates the migration of vascular endothelial cells (PubMed:17540773). Required for normal extraembryonic angiogenesis and for embryonic heart development (By similarity). May regulate endothelial cell shape changes in response to blood flow, which drive vascular remodeling and establishment of normal vascular morphology during angiogenesis (By similarity). May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors (PubMed:1692830). Acts as TGF-beta coreceptor and is involved in the TGF-beta/BMP signaling cascade that ultimately leads to the activation of SMAD transcription factors (PubMed:8370410, PubMed:21737454, PubMed:22347366, PubMed:23300529). Required for GDF2/BMP9 signaling through SMAD1 in endothelial cells and modulates TGFB1 signaling through SMAD3 (PubMed:21737454, PubMed:22347366, PubMed:23300529). (updated: June 20, 2018)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  3. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology, is annotated as membranous in UniProt, is predicted to be membranous by TOPCONS.


Interpro domains
Total structural coverage: 0%
Model score: 0
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
dbSNP:rs35400405
HHT1
HHT1
HHT1
HHT1; impairs protein folding; abolishes expression at the cell surface
HHT1; impairs protein folding; abolishes expression at the cell surface
HHT1
HHT1
HHT1
Found in a family with hereditary hemorrhagic talagiectasia; unknown pathological significance
HHT1
HHT1
empty
HHT1
HHT1
HHT1
Found in a patient with hereditary hemorrhagic talagiectasia
HHT1
HHT1
HHT1
HHT1
HHT1
HHT1
Found in a family with hereditary hemorrhagic talagiectasia
HHT1
dbSNP:rs1800956
Found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance
HHT1
HHT1
HHT1
Found in a patient with hereditary hemorrhagic talagiectasia; unknown pathological significance
HHT1
HHT1
HHT1
HHT1
HHT1
HHT1
dbSNP:rs142896669
HHT1
Found in a patient with hereditary hemorrhagic talagiectasia
dbSNP:rs375965489
HHT1
HHT1
dbSNP:rs148002300

Biological Process

Angiogenesis GO Logo
Artery morphogenesis GO Logo
Atrial cardiac muscle tissue morphogenesis GO Logo
Atrioventricular canal morphogenesis GO Logo
BMP signaling pathway GO Logo
Bone development GO Logo
Branching involved in blood vessel morphogenesis GO Logo
Cardiac atrium morphogenesis GO Logo
Cardiac ventricle morphogenesis GO Logo
Cell adhesion GO Logo
Cell chemotaxis GO Logo
Cell migration GO Logo
Cell migration involved in endocardial cushion formation GO Logo
Cell motility GO Logo
Cellular response to mechanical stimulus GO Logo
Central nervous system vasculogenesis GO Logo
Detection of hypoxia GO Logo
Dorsal aorta morphogenesis GO Logo
Endocardial cushion morphogenesis GO Logo
Epithelial to mesenchymal transition GO Logo
Epithelial to mesenchymal transition involved in endocardial cushion formation GO Logo
Extracellular matrix constituent secretion GO Logo
Extracellular matrix disassembly GO Logo
Heart looping GO Logo
Intracellular signal transduction GO Logo
Negative regulation of cell migration GO Logo
Negative regulation of endothelial cell proliferation GO Logo
Negative regulation of gene expression GO Logo
Negative regulation of nitric-oxide synthase activity GO Logo
Negative regulation of pathway-restricted SMAD protein phosphorylation GO Logo
Negative regulation of protein autophosphorylation GO Logo
Negative regulation of transcription by RNA polymerase II GO Logo
Negative regulation of transforming growth factor beta receptor signaling pathway GO Logo
Obsolete chronological cell aging GO Logo
Outflow tract septum morphogenesis GO Logo
Positive regulation of angiogenesis GO Logo
Positive regulation of BMP signaling pathway GO Logo
Positive regulation of collagen biosynthetic process GO Logo
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO Logo
Positive regulation of gene expression GO Logo
Positive regulation of pathway-restricted SMAD protein phosphorylation GO Logo
Positive regulation of protein kinase B signaling GO Logo
Positive regulation of protein phosphorylation GO Logo
Positive regulation of systemic arterial blood pressure GO Logo
Positive regulation of transcription by RNA polymerase II GO Logo
Positive regulation of vascular associated smooth muscle cell differentiation GO Logo
Regulation of cell adhesion GO Logo
Regulation of cell population proliferation GO Logo
Regulation of phosphorylation GO Logo
Regulation of transcription, DNA-templated GO Logo
Regulation of transforming growth factor beta receptor signaling pathway GO Logo
Response to corticosteroid GO Logo
Response to drug GO Logo
Response to hypoxia GO Logo
Response to statin GO Logo
Response to transforming growth factor beta GO Logo
Smooth muscle tissue development GO Logo
Transforming growth factor beta receptor signaling pathway GO Logo
Vascular associated smooth muscle cell development GO Logo
Vasculogenesis GO Logo
Venous blood vessel morphogenesis GO Logo
Ventricular trabecula myocardium morphogenesis GO Logo
Wound healing GO Logo

The reference OMIM entry for this protein is 131195

Endoglin; eng
Cd105

DESCRIPTION

Endoglin (ENG), also called CD105, is a homodimeric membrane glycoprotein primarily associated with human vascular endothelium. It is also found on bone marrow proerythroblasts, activated monocytes, and lymphoblasts in childhood leukemia. Endoglin is a component of the transforming growth factor-beta (TGFB) receptor complex and binds TGFB1 (190180) with high affinity (Rius et al., 1998).

CLONING

Gougos and Letarte (1990) isolated a cDNA encoding ENG lacking a leader sequence from an endothelial cell cDNA library. By screening a leukemia cell cDNA library, Bellon et al. (1993) obtained full-length cDNAs encoding 2 variants of ENG. Both contain a 25-amino acid leader peptide, followed by 561 residues in the extracellular portion and a 25-amino acid transmembrane sequence. However, the long variant has a 47-amino acid cytoplasmic tail, while the tail of the short variant contains only 14 residues. Flow cytometric and immunoprecipitation analyses indicated high expression of both the 160- and 170-kD disulfide-linked homodimer ENG variants at the cell surface. RT-PCR analysis detected expression of both variants on activated monocytes, endothelial cells, and placenta, with the long form being predominant.

GENE FUNCTION

Bellon et al. (1993) found that both isoforms of ENG could bind TGFB1. Rius et al. (1998) cloned and characterized the promoter region of the ENG gene. They showed that the endoglin promoter exhibits inducibility in the presence of TGFB1, suggesting possible therapeutic treatments in HHT1 (187300) patients, in which the expression level of the normal endoglin allele might not reach the threshold required for its function. Grisanti et al. (2004) analyzed endoglin expression in choroidal neovascular membranes (CNVMs) surgically excised from eyes with age-related macular degeneration (ARMD; see 153800). Endoglin expression was increased in the endothelial cells of CNVMs but was rarely associated with a concomitant expression of the proliferation marker Ki-67 (176741). The authors concluded that the elevated expression of endoglin in the surgically excised CNVMs suggested a persisting postmitotic activation in an advanced stage of neovascular tissue. Hereditary hemorrhagic telangiectasia (see 187300) and cerebral cavernous malformations (see 116860) are disorders involving disruption of normal vascular morphogenesis. The autosomal dominant mode of inheritance in both of these disorders suggested to Marchuk et al. (2003) that their underlying genes might regulate critical aspects of vascular morphogenesis. The authors summarized the roles of these genes, endoglin, KRIT1 (604214), and ALK1 (ACVRL1; 601284), in the genetic control of angiogenesis. Lebrin et al. (2004) found that mouse endothelial cells lacking endoglin did not grow because Tgfb/Alk1 signaling was reduced and Tgfb/Alk5 (190181) signaling was increased. Surviving cells adapted to the imbalance and proliferated by downregulating Alk5 expression. Lebrin et al. (2004) concluded that endoglin has a role in the balance of ALK1 and ALK5 signaling to regulate endothelial cell proliferation. GIPC1 (605072) is a scaffolding protein that regulates cell surface receptor expression and trafficking. Using predominantly embryonic mouse endothelial cell lines, Lee et al. (2008) showed that endoglin and Gipc interacted directly. The interaction enhanced TGF-beta-1-induced phosphorylation of Smad1 (601595)/Smad5 (603110)/Smad8 (SMAD9; 603295 ... More on the omim web site

Subscribe to this protein entry history

July 2, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 10, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 131195 was added.